Evidence map›Paper›PMID 34484359›Full record

ArticleJournal of contemporary brachytherapy2021

Advanced dose calculation algorithm in superficial brachytherapy - the impact of tissue inhomogeneity on treatment plan dosimetry.

Marta Szlag, Sylwia Kellas-Śleczka, Piotr Wojcieszek, Magdalena Stankiewicz, Agnieszka Cholewka, Agnieszka Pruefer, Tomasz Krzysztofiak, Piotr Lelek, Małgorzata Stąpór-Fudzińska, Krzysztof Ślosarek

Abstract read
In one paragraph

Article in Journal of contemporary brachytherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marta SzlagTreatment Planning Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Poland.
Sylwia Kellas-ŚleczkaBrachytherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Poland.
Piotr WojcieszekBrachytherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Poland.
Magdalena StankiewiczBrachytherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Poland.
Agnieszka CholewkaTreatment Planning Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Poland.
Agnieszka PrueferTreatment Planning Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Poland.
Tomasz KrzysztofiakBrachytherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Poland.
Piotr LelekBrachytherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Poland.
Małgorzata Stąpór-FudzińskaTreatment Planning Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Poland.
Krzysztof ŚlosarekTreatment Planning Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGiven tissue inhomogeneity and lack of backscatter media, superficial brachytherapy necessitates more accurate dosimetry than TG-43 formalism. However, the introduction of modern model-based dose calculation algorithms into clinical practice should be carefully evaluated. The aim of this work was to compare dose distributions calculated with TG-43 and advanced collapsed cone engine (ACE) algorithms for individual multi-catheter moulds, and investigate the impact of target size and the lack of bolus to differences between plans. MATERIAL AND

methodsEleven treatment plans for individual mould multi-catheter high-dose-rate brachytherapy (IMM HDR) were selected for retrospective analysis. All treatment plans were initially calculated with TG-43 formula and re-calculated using ACE algorithm. Plan re-calculation with ACE was repeated for each plan in order to assess the impact of bolus. To evaluate differences between TG-43 and ACE dose distributions, dose-volume histogram (DVH) parameters for each ROI were compared. D

resultsA significantly lower values (

conclusionsResults show that differences between dosimetric parameters are statistically significant. However, their clinical relevance is still undetermined. Careful re-evaluation of the clinical results based on long-term research on TG-43 is necessary to safely introduce modern algorithms to clinical practice.

Indexed as

model-based dose-calculation algorithmsmouldsskin brachytherapyTG-186

Identifiers

PMID34484359
PMCPMC8407266

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.